SIBO in NASH individuals is also associated with enhanced hepatic expression of TLR4 and release of interleukin (IL)-8 supporting the hypothesis that SIBO may have an important role in NASH development and progression [14]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.